Lupin on a massive expansion. Lupin has added close to 1,300 representatives, seven divisions in the last nine months, 21 new products. Doing very well on new product introductions as well. The company is open for acquisitions and can turn debt free going forward. On exports front too growth turned positive with USFDA approvals picking up momentum. The company has given margin guidance of 19.5 to 20.5 percent which is very good.
MARKET VIEW
OUTLOOK
SECTORS
STRATEGY
VIEW
PERSONAL FINANCE
INSURANCE
INVEST
MUTUAL FUND
GENERAL